50
Participants
Start Date
July 26, 2013
Primary Completion Date
June 2, 2017
Study Completion Date
June 2, 2017
EPA and high dose rosuvastatin
After randomization, patients with intensive lipid lowering therapy start EPA (1800mg/day) and high dose rosuvastatin (10mg/day) for 12 months.
Standard dose rosuvastatin
After randomization, patients with standard lipid lowering therapy start only rosuvastatin (2.5mg/day) for 12 months.
Kobe University
INDUSTRY